Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Cancers|April 26, 2025
Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk PopulationsCecilia Monge, Brigette Waldrup, Francisco G Carranza, et al.JCO Global Oncology|March 13, 2025
Disparities in Cholangiocarcinoma Research and Trials: Challenges and Opportunities in the United StatesOyepeju F Abioye, Rebekah Kaufman, Tim F Greten, et al.Journal of Hepatocellular Carcinoma|August 3, 2023
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United StatesCecilia Monge, J Alberto Maldonado, Katherine A McGlynn, et al.International Journal of Molecular Sciences|August 28, 2025
Pathway-Specific Genomic Alterations in Pancreatic Cancer Across Populations at RiskCecilia Monge, Brigette Waldrup, Francisco G Carranza, et al.Cancer Medicine|April 1, 2025
Detecting PI3K and TP53 Pathway Disruptions in Early-Onset Colorectal Cancer Among Hispanic/Latino PatientsCecilia Monge, Brigette Waldrup, Sophia Manjarrez, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 24, 2025
Myeloid-derived suppressor cells modulation in the context of tumor microenvironment for gastric cancerJosé Dario Portillo-Miño, Jhon Jairo Calderón, Erika Ruiz-García, et al.Carcinogenesis|July 10, 2023
The current landscape of therapies for hepatocellular carcinomaKelley Coffman-D'Annibale, Changqing Xie, Donna M Hrones, et al.Heliyon|December 23, 2022
Reciprocity heightens academic performance in elementary school studentsCristian Candia, Melanie Oyarzún, Victor Landaeta, et al.Journal for Immunotherapy of Cancer|December 20, 2018
Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case reportCecilia Monge, Hoyoung Maeng, Alessandra Brofferio, et al.Journal of the National Cancer Institute. Monographs|February 24, 2025
Global perspectives on patient-centered outcomes: advancing patient-centered cancer clinical trials globallyCecilia Monge, Linsey Eldridge, Paul C Pearlman, et al.Pageof 5